Federal investment in basic science built America’s innovation engine, but declining support is threatening U.S. leadership, writes Dietrich Stephan, Ph.D.
By bringing objective evaluation, expertise, and effective change management skills, learn how interim staff can improve an institution’s ability to identify issues and implement necessary changes.
Fragmented oversight can hinder gene therapy programs. See how a real-time, integrated operating model improves visibility, accelerates decisions, and supports reliable delivery.
Integrated oversight helps teams interpret early safety signals in context, enabling targeted action, reducing escalation, and preventing disruptions in complex studies with limited data.
In the field of mRNA therapeutics, residual double-stranded RNA (dsRNA) remains a significant safety concern. Learn how an optimized dsRNA detection method helps improve quality and safety in mRNA-based drugs.
Discover how innovative and safer synthetic strategies can streamline the manufacture of Upadacitinib while addressing the complexity and safety challenges inherent in its key intermediates.
